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Knowledge on the molecular mechanisms involved in memory retrieval is limited due to 
the lack of tools to study this stage of the memory process. Here we report that exchange 
proteins activated by cAMP (Epac) play a surprisingly specific role in memory retrieval. 
Intrahippocampal injection of the Epac activator 8-pCPT-2’O-Me-cAMP was shown to 
improve fear memory retrieval in contextual fear conditioning whereas acquisition and 
consolidation were not affected. The retrieval enhancing effect of the Epac activator was 
even more prominent in the passive avoidance paradigm. Downregulation of Epac2 
expression in the hippocampal CA1 area impaired fear memory retrieval when the memory 
test was performed 72 h after training, but not when tested after 17 days. Our data thus 
identify an important time-limited role for hippocampal Epac2 signaling in cognition and 
opens new avenues to investigate the molecular mechanisms underlying memory retrieval. 
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Introduction 
 
To date significant advances have been made in understanding the neurophysiological basis 
of learning and memory. In particular, cyclic adenosine monophosphate (cAMP) signaling 
was shown to play a pivotal role. Originally cAMP-dependent protein kinase (PKA) was 
thought to be the major if not the sole effector of cAMP and its importance in memory 
consolidation is now widely acknowledged (Abel & Nguyen, 2008). However, fairly 
recently, a new effector of cAMP signaling has been identified named exchange protein 
directly activated by cAMP (Epac). In independent studies, two variants of the Epac 
protein, namely Epac1 (also called cAMP-GEF-I) and Epac2 (also called cAMP-GEF-II), 
were characterized (de Rooij et al., 1998; Kawasaki et al., 1998). Both Epac proteins are 
multi-domain proteins that function as guanine-nucleotide-exchange factors (GEFs) for 
Rap1 and Rap2, members of the Ras superfamily of small GTPases. Activation of Epac by 
cAMP leads to activation of Rap1 and Rap2, which then act as molecular switches on 
downstream signaling cascades. While Epac1 has one cAMP binding domain, Epac2 
possesses a similar additional domain, the biological function of which is still unknown 
(Bos, 2006). The two Epac variants also differ in their expression patterns. Epac1 has been 
found to be expressed ubiquitously, whereas expression of Epac2 was found mainly in 
adrenal glands and brain tissue (Kawasaki et al., 1998).  
Since their discovery, Epac proteins have been found to control key cellular processes, 
including cellular calcium handling, integrin-mediated cell adhesion, gene expression, 
cardiac hypertrophy, inflammation, and exocytosis (Roscioni et al., 2008). However, the 
exact nature of any involvement that Epacs have in neuronal function, has only recently 
begun to be investigated. Epac was shown to enhance neurotransmitter release in 
glutamatergic synapses (Sakaba & Neher, 2003; Zhong & Zucker, 2005; Gekel & Neher, 
2008), whereas in cerebellar granule cells it can modulate neuronal excitability (Ster et al., 
2007). In dorsal root ganglion Epac mediates the translocation and activation of protein 
kinase C (PKC)  leading to the establishment of inflammatory pain (Hucho et al., 2005) and 
promotes neurite outgrowth (Murray & Shewan, 2008). In spinal cord tissue Epac advances 
neurite regeneration (Murray & Shewan, 2008). 
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Thus far, evidence for a role of Epac in the process of learning and memory is limited. 
However, since Epac is a cAMP-responsive enzyme and cAMP signaling is established to 
be of critical importance in learning and memory, an involvement of PKA-independent 
cAMP signaling through Epac proteins can be expected. Indeed the first indications for a 
role of Epac in hippocampus-dependent learning and memory came from very recent 
studies. Gelinas and colleagues reported that Epac activation enhances the maintenance of 
LTP in area CA1 of mouse hippocampal slices (Gelinas et al., 2008) and co-application of a 
selective PKA and a selective Epac activator was shown to rescue the memory retrieval 
impairment observed in dopamine-beta-hydroxylase deficient mice whereas application of 
the Epac activator alone had no effect (Ouyang et al., 2008). In the current study we 
investigated the role of Epac signaling in the different phases of the memory process; 
acquisition, consolidation and retrieval. Epac signaling via Epac2 was shown to play a 
specific and time-limited role in memory retrieval. 
 
 
Materials and methods 
 
Animals and housing conditions 
Male C57BL/6J mice (Harlan, Horst, the Netherlands), 9 to 12 weeks old, were individually 
housed in standard macrolon cages. Subjects were maintained on a 12 hour light/dark cycle 
(lights on at 7.30 a.m.) with food (hopefarm® standard rodent pellets) and water ad libitum. 
A layer of sawdust served as bedding. The procedures concerning animal care and 
treatment were in accordance with the regulations of the ethical committee for the use of 
experimental animals of the University of Groningen (DEC 4174I-K). 
 
Cannulation 
Double guide cannulae (C235, Plastics One, Roanoke, VA) were implanted using a 
stereotactic holder during 1.2 % avertin anesthesia (0.02 ml/g, i.p.) under aseptic conditions 
(Nijholt et al., 2008). The cannulae were placed into both dorsal hippocampi 
(intrahippocampal; i.h.), AP –1.5 mm, lateral 1 mm, depth 2 mm (Franklin & Paxinos, 
1997). The animals were allowed to recover for 6-7 d before the experiments started. 
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Bilateral injections were performed during a short anesthetic period of isoflurane inhalation 
using a syringe pump (TSE systems, Bad Homburg, Germany) at a constant rate of 0.33 
µl/min (final volume: 0.3 µl per side). The exact site of injection was confirmed after the 
behavioral experiments by injection of methylene blue solution into each hemisphere and 
subsequent histological evaluation (Fig. 5A). Data were evaluated only from those mice 
that received an injection at the correct target site. 
 
Drug treatment 
The Epac activator 8-pCPT-2’O-Me-cAMP (Biolog, Bremen, Germany) was injected in a 
final concentration of 1 mM (300 ng/brain) in artificial cerebrospinal fluid (ACSF) solution 
of the following composition (in mM): 130 NaCl, 3.5 KCl, 1.25 NaH2PO4, 1.5 MgSO4, 2 
CaCl2, 24 NaHCO3, and 10 glucose (pH 7.4). 8-pCPT-2’O-Me-cAMP was stored as a 100 
mM stock solution in H2O. A separate set of animals was injected with vehicle (ACSF 
pH=7.4). Untreated animals without cannula served as controls for possible cannulation and 
injection effects.  
 
Fear Conditioning  
Fear conditioning was performed as described before (Nijholt et al., 2008) in a Plexiglas 
cage (44 x 22 x 44 cm) with constant illumination (12 V, 10 W halogen lamp, 100-500 lux). 
The training (conditioning) consisted of a single trial. The mouse was exposed to the 
conditioning context for 180 sec followed by a footshock (0.7 mA, 2 sec, constant current) 
delivered through a stainless steel grid floor. The mouse was removed from the fear 
conditioning box 30 sec after shock termination to avoid an aversive association with the 
handling procedure. Memory tests were performed 24 hr, 72 h or 14 days after fear 
conditioning. Contextual memory was tested in the fear conditioning box for 180 sec 
without footshock presentation. Freezing, defined as the lack of movement except for 
respiration and heart beat, was assessed as the behavioral parameter of the defensive 
reaction of mice by a time-sampling procedure every 10 s throughout memory tests. In 
addition, mean activity of the animal during the training and retention test was measured 





Passive avoidance experiments were performed in a plexiglas cage (44 x 22 x 44 cm) 
consisting of a dark compartment (22 x 22 x 20 cm) equipped with a stainless steel grid 
floor and a light compartment (22 x 22 x 44 cm) with a plastic floor. Both compartments 
were separated by a guillotine door. The light compartment was brightly illuminated by a 
100 W bulb. Mice were habituated to the experimental set-up during three sessions 30, 24 
and 6 hr prior to the training session. During habituation sessions, the mouse was 
introduced into the light compartment facing the closed guillotine door. After 60 sec the 
door was opened and the mouse was allowed to enter the dark compartment. Upon entering 
the dark compartment the door was closed and the mouse was allowed to explore the 
compartment for 60 sec. During the training session, the mouse was again introduced into 
the light compartment, and the guillotine door was opened after 60 sec. Latency (defined as 
the time between the opening of the door and the mouse entering the dark compartment 
with all four paws) was recorded for each animal. Upon entering the dark chamber the door 
was closed and a single footshock (0.3 mA, 2 sec, constant current) was delivered to the 
mouse. The mouse was removed from the apparatus 30 sec after shock termination to avoid 
an aversive association with the handling procedure. Memory tests were performed 24 hr 
after training. During the memory test the guillotine door was opened 60 sec after 
introducing the mouse into the light compartment and left opened for maximally 480 sec. 
During this time period, latency to enter the dark compartment was recorded and assessed 
as the behavioral parameter. If a mouse did not enter the dark compartment, latency was set 
to 480 sec. 
 
Elevated plus maze 
Elevated plus maze experiments were performed using a plus maze (50 cm above the floor) 
with two opposite closed and two opposite open arms (50 cm long, 5 cm wide). The mouse 
was placed in the central zone of the plus maze, facing an open arm and allowed to explore 
the maze for 480 sec. Time spent in dark arms, open arms and center compartment were 
recorded for each animal with the Ethovision system (Noldus, The Netherlands). The ratio 
of time spent in the open arms to total time spent in the maze was calculated for each group 
 124
Epac2 in memory retrieval 
of mice and taken as a measure of anxiety-related behaviour, with a higher ratio being 
indicative of lower anxiety levels. 
 
Immunohistochemistry 
30 µm thick coronal sections of C57Bl/6J mice perfused with 4 % paraformaldehyde, were 
preincubated with 0.3 % H2O2 to reduce endogenous peroxidase. Non-specific binding 
sites were blocked by preincubating the sections with 5 % normal goat serum in 0.01 M 
PBS for 30 min. Subsequently, sections were probed with antibodies specific for Epac1 
(from 1:300 to 1:1000, several batches [1C8, 4D9 and 5D3] kindly provided by J. Bos, 
University Utrecht, the Netherlands and  Epac1 A5, sc-28360, Santa Cruz) or Epac2 
(1:1000) (2B12, provided by J. Bos) in 0.01 M PBS containing 5 % normal goat serum and 
0.3 % Triton X-100 for 2 h at room temperature (RT) and subsequently for 72 h  at 4 °C. 
After several washing steps, sections were incubated with biotin SP-Conjugated AffiniPure 
goat anti mouse secondary antibody overnight at 4 °C (1:400) (115-065-166, Jackson 
Laboratories INC) followed by the ABC complex (Vector ABC kit). For visualization, 
DAB was used as a chromogen (Sigma fast tablet set). Sections were examined using light 
microscopy. The specificity of Epac antibodies was assessed by parallel staining without 
primary antibodies. In these sections we could not observe any staining (data not shown). 
Photographs were taken with a DM1000/DFC280 Leica image analysis system (Leica, 
Cambridge, UK). 
 
Semi-quantitative RT-PCR  
To determine Epac1 and Epac2 mRNA levels in the mouse hippocampus, total RNA was 
extracted from a single hippocampus of a naive mouse (n=5). Total RNA was isolated 
according to the manufacturer’s protocol (NucleoSpin RNA II kit, Macherey-Nagel, 
740955.250). RT-PCR was performed using Superscript III One-Step RT-PCR with 
Platinum Taq DNA Polymerase (Invitrogen, 12574) as described before (Nijholt et al., 
2004). 120 ng of RNA was used for each RT-PCR reaction. The reverse transcriptase 
reaction was performed at 55 °C for 30 min. PCR cycling was at 94 °C for 15 sec, 
annealing at 55 °C for 30 sec, extension at 72 °C for 30 sec and a final extension at 72 °C 
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for 10 min. 10 µl of each sample was removed every 3 cycles from 25 to 37 cycles in each 
reaction to amplify Epac1 and Epac2.  
To test the efficiency of the siRNA probes, hippocampi were collected 24 hr after the last 
siRNA injection and the injection site excised. Total RNA isolation and the reverse 
transcriptase reaction were performed as described above. Hypoxanthine-guanine 
phosphoribosyltransferase (HPRT) served as control housekeeping gene. 10 µl of each 
sample was removed every 3 cycles from 27 to 50 cycles in each reaction to amplify Epac1, 
Epac2 and HPRT fragments. 
Amplified PCR products were separated on 2 % agarose gels with Tris-borate EDTA buffer 
and stained with SYBR Green (Invitrogen). Gels were captured as a digital image and 
quantified by densitometry. Primer sequences for Epac1 were: forward 5’-
GTTGTCGACCCACAGGAAGT-3’ and reverse 5’-ACCCAGTACTGCAGCTCGTT-3’, 
for Epac 2 were: forward 5’-CATGAGGGGAACAAGACGTT-3’ and reverse 5’ GGCC-
TTCGAGGCTCTAATCT 3’ and for HPRT forward primer 5’-CCTGCTGGATTACATT-
AAAGCACTG-3’ and reverse 5’-CCTGAAGTACTCATTATAGTCAAGG-3’.  
 
In vivo siRNA transfection  
Mice injected i.h. with 50 ng siGLO Green (25 ng/hippocampus; D-001630-01-05, 
Dharmacon, Inc. Lafayette, CO, USA), were sacrificed 6, 24 or 48 hr post injection. The 
brain hemispheres were placed in a 4 % PFA solution for 24 hr, followed by 48 hr 30 % 
sucrose immersion. Afterwards, 30 µm thick coronal sections were stained with DAPI 
(1:5000) in PBS 0.01 M. After a quick washing step in PBS 0.01 M, sections were 
mounted, dried and analyzed under a Leica fluorescent microscope.  
ON-TARGET plus SMART pool mouse RAPGEF3 (Epac1 siRNA) and RAPGEF4 (Epac2 
siRNA) probes were purchased from Dharmacon, (Dharmacon, USA). The target sequences 
for the mouse-specific Epac1 siRNAs mixture were as follows: sense: 
CCAGGCAGGAACCGGUAUAUU (J-057800-09); sense: GAUCUUUGUUCACGGCC-
AAUU (057800-10); sense: GGUCAAUUCUGCCGGUGAUUU (057800-11) and sense: 
CCACCAUCAUCCUUCGAGAUU (057800-12). The target sequences for the mouse-
specific Epac2 siRNAs mixture were: sense: CGAAAGACCUGGCGUACCAUU (J-
057784-05); sense: CAAGUUAGCUCUAGUGAACUU (J-057784-06); sense: GACAGA-
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AAGUACCACCUAAUU (J-057784-07) and sense: GGAGGAACUGUGUUGUUUAUU. 
ON-TARGETplus Non-targeting Poll siRNA (D-001810-10) was used as control 
(Dharmacon, USA). siRNAs were resuspended in RNAse free water. In vivo siRNA brain 
delivery was performed using jetSI 10 mM cationic polymer transfection reagent (Polyplus 
transfection Inc., New York) according to the transfection protocol of the manufacturer. 50 
ng siRNA was injected i.h. on three consecutive days 3, 24 and 48 hr after training or on the 
three days prior to the second retention test.  
 
Statistics 
Statistical comparisons were made by analysis of variance (ANOVA). For each significant 
F ratio, Fisher's protected least significant difference (PLSD) test was used to analyze the 
statistical significance of appropriate multiple comparisons. Data were expressed as mean ± 





Intrahippocampal Epac activation facilitates memory retrieval in contextual fear 
conditioning 
The role of Epac in the different stages of the memory process was investigated using one 
trial contextual fear conditioning. Contextual fear conditioning is a hippocampus-dependent 
form of associative learning in which animals learn to fear a new environment because of 
its temporal association with an aversive mild electrical footshock. When injected 
intrahippocampally (i.h.) 20 min before training, the specific Epac activator 8-pCPT-2’O-
Me-cAMP caused no significant change in freezing behavior during the retention test 24 hr 
after training in comparison to vehicle-injected and untreated mice (one-way ANOVA: 
F(2,25) = 1.110; p = 0.312, Fig. 1A). Injection of 8-pCPT-2’O-Me-cAMP or vehicle did not 
result in changes in mean activity or shock reactivity during training (data not shown). 
Moreover, no significant difference in freezing behavior was observed between groups 
during the retention test when 8-pCPT-2’O-Me-cAMP was injected immediately after 
training (one-way ANOVA: F(2,18) = 0.032; p = 0.969, Fig. 1B).  
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To determine the effect of Epac activation on the retrieval of fear memory, mice were 
injected i.h. with 8-pCPT-2’O-Me-cAMP or vehicle 20 min before the retention test. 
Injection of 8-pCPT-2’O-Me-cAMP resulted in a significant increase in freezing behavior 
during the retention when compared to vehicle-injected and untreated animals (one-way 






















































































































Fig. 1. Intrahippocampal injection of Epac activator 8-pCPT-2’O-Me-cAMP (1 mM) facilitates the retrieval of 
contextual fear memory. Mice were injected either 20 min before training (A, immediately after training (B), or 20 
min before retention (C) with 8-pCPT-2’O-Me-cAMP (1 mM) or vehicle. Untreated and vehicle-injected mice 
served as controls. Freezing behaviour was measured in the memory test 24 h after training. Error bars indicate 
standard error of the mean. Statistically significant differences: *p < 0.05 versus control groups. 
 
Taken together, these data show that Epac activation in the hippocampus modulated the 
retrieval of contextual fear memory, but not acquisition or consolidation. 
 
Intrahippocampal Epac activation facilitates memory retrieval in passive avoidance 
The effect of i.h. 8-pCPT-2’O-Me-cAMP injection on memory retrieval was also tested in 
the passive avoidance task. In this one trial fear-motivated avoidance task the animal learns 
to refrain from stepping through a door to an apparently safer but previously punished dark 
compartment. It is considered to be more complex than fear conditioning due to the 
combination of classical Pavlovian conditioning with the manifestation of an active 
response. Mice were habituated to the experimental set-up during three sessions prior to the 
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training session. We did not observe any difference between groups in their latencies to 
enter the dark compartment during the training session (one-way ANOVA: F(2,23) = 0.917, 
p = 0.414, Fig. 2A). The next day, one group of mice was injected i.h. with 8-pCPT-2’O-
Me-cAMP (1 mM) 20 min before the retention test. Untreated and vehicle injected mice 
served as controls. Mice injected with 8-pCPT-2’O-Me-cAMP showed a significantly 
longer latency to enter the dark compartment when compared to the control groups (one-
way ANOVA: F(2,23) = 4.650, p = 0.020, Fig. 2B). Overall, the memory retrieval 
enhancing effect of 8-pCPT-2’O-Me-cAMP in the passive avoidance paradigm was even 






















































































Fig. 2. Intrahippocampal injection of the Epac activator 8-pCPT-2’O-Me-cAMP (1 mM) facilitates memory 
retrieval in the passive avoidance paradigm. Mice were habituated to the experimental set-up during three sessions. 
Mice were injected with 8-pCPT-2’O-Me-cAMP or vehicle 20 min before the retention test. Untreated and 
vehicle-injected mice served as controls. Latency to enter the dark compartment during training (A) and the 
retention test (B). Error bars indicate standard error of the mean. Statistically significant differences: *p < 0.05 
versus control groups. 
 
 Intrahippocampal Epac activation does not affect anxiety 
The performance of the mice in the retention tests may be influenced by the level of anxiety 
the animal experiences. Therefore, we tested the effect of 8-pCPT-2’O-Me-cAMP on 
anxiety behavior in an elevated plus maze.  Intrahippocampal 8-pCPT-2’O-Me-cAMP (1 
mM) injection 20 min before exposure to the elevated plus maze test did not specifically 
affect anxiety behavior (one-way ANOVA: F(2,19) = 1.741; p = 0.202, Fig 3). Cannulated 
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animals, i.e. 8-pCPT-2’O-Me-cAMP-injected and vehicle-injected mice, did show slightly, 
but not significantly higher levels of anxiety, which can be explained by the surgery 
procedure these animals underwent 6-7 days prior to testing in the elevated plus maze.  
 
Fig. 3. Intrahippocampal injection of 8-pCPT-2’O-Me-cAMP (1 
mM) does not affect anxiety. Mice were injected with 8-pCPT-
2’O-Me-cAMP or vehicle 20 min before the test. Untreated and 
vehicle-injected mice served as controls. Time spent in the 
different compartments of the maze was measured during 480 
sec and ratio between time in open arms and total time in maze 
was taken as a measure of anxiety. Error bars indicate standard 

















































Since injection of 8-pCPT-2’O-Me-cAMP did not affect anxiety in the elevated plus maze 
test, the effect of Epac activation by 8-pCPT-2’O-Me-cAMP in the fear-motivated learning 
tasks can be ascribed to enhanced memory retrieval of the association between the electric 
footshock and the context. 
 
Epac expression in the mouse brain  
Next we determined the distribution of Epac1 and Epac2 in the mouse brain. Epac2 was 
shown to be abundantly expressed throughout the entire mouse brain (Fig. 4A).  
High levels were detected in the cortex, hippocampus and thalamus. In the hippocampal 
cellular layers such as the stratum pyramidale (Py) and the granule layer (GCL) 
immunoreactivity was rather low whereas the basal and apical dendrites [stratum oriens 
(SO), stratum radiatum (SR), the stratum lacunosum moleculare (SLM) and molecular layer 
(ML)] showed a high Epac2 expression (Fig. 4B). For Epac1 staining, four different Epac1 
antibodies (up to antibody saturation levels) were tested. Although positive Epac1 staining 
was observed with these antibodies in lung and heart tissue (M. Schmidt, unpublished data), 
no positive Epac1 staining could be detected in the brain (data not shown). Thus, it appears 
that Epac1 expression is very low in mouse brain. Moreover, semi-quantitative RT-PCR for 
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Epac1 and Epac2 with mRNA isolated from the hippocampus, showed that Epac2 mRNA 
could be detected much earlier as Epac1 mRNA (Fig. 4C). 
 
Fig. 4. Detection of Epac1 and Epac2 in mouse brain. A. 
Semi-quantitative RT-PCR experiment for Epac1 and Epac2. 
Epac2 mRNA could be detected after a lower amount of 
cycles as Epac1 mRNA. A representative experiment is 
presented. B. Epac2 staining in the mouse brain: caudate 
putamen (Cpu), hippocampus (H), ventrolateral thalamic 
nucleus (VL), anterior hypothalamic area (AH). C. Epac2 
Immunoreactivity in the hippocampus: stratum pyramidale 
(Py), stratum oriens (SO), stratum radiatum (SR), stratum 
lacunosum moleculare (SLM) and molecular layer (ML) 























Our data are consistent with a previous study from Kawasaki and colleagues who also 
reported a high expression of Epac2 in the rat brain whereas Epac1 was barely detectable 
(Kawasaki et al., 1998).  
 
Intrahippocampal Epac2 siRNA injection impairs fear memory retrieval 
To investigate the role of hippocampal Epac2 in memory retrieval, we specifically 
downregulated Epac2 expression before the memory test using in vivo lipid mediated 
siRNA gene silencing. A previous study already showed the efficient downregulation of 
Epac2 expression by these siRNA probes in in vitro neuronal cell cultures (Nijholt et al., 
2008). To check for siRNA transfection efficiency in the in vivo mouse brain, we first 
injected mice i.h. with fluorescent siGLO green (Fig. 5A,B). A single bilateral injection of 
siGLO green resulted in a strong fluorescent signal in the pyramidal cell layer of the CA1 
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area already as early as 6 hr after injection. The signal lasted at least up to 48 h after 
injection. Other brain areas were not affected by the treatment. 
Downregulation of Epac2 expression by i.h. injection of specific siRNA probes on three 
consecutive days was verified by semi-quantitative RT-PCR on the fourth day. Injection of 
Epac2 siRNA resulted in a 47 % reduction of hippocampal Epac2 mRNA (Fig 5C,D). The 
low level of Epac1 mRNA was not affected by the transfection with Epac2 siRNA.  
 
















































Fig. 5. Efficient downregulation of hippocampal Epac2 expression by in vivo siRNA transfection. A. left panel: 
coronal brain section of the mouse brain atlas (Franklin and Paxinos, 1997), black dot indicates the injection site, 
right panel: photomicrograph showing a representative detail of a coronal brain section after hippocampal injection 
of methylene blue counterstained with nuclear fast red. DG, dentate gyrus; CA1, CA1 area of the hippocampus; 
CA3, CA3 area of the hippocampus. B. Representative fluorescent microphotographs showing siGLO green 
transfection into the pyramidal neurons of the CA1 area indicated by an arrow. A DAPI staining was used to 
identify nuclear staining. C. Bar graphs show the ratio of Epac2 mRNA band intensities verified to be within the 
linear range of product accumulation, divided by those of the coamplified HPRT product after 34 cycles. 
Statistically significant difference: *p < 0.05 versus control groups. D. Bands reflect the levels of Epac1 and Epac2 
mRNA expression after 34 cycles.  
 
In the behavioral experiments, mice were injected i.h. with Epac2 siRNA (50 ng/brain) 3 
hr, 24 hr and 48 hr after training in a contextual fear conditioning paradigm (Fig. 6A). 
Epac2 siRNA injection completely abolished the 8-pCPT-2’O-Me-cAMP-induced 
enhancement of retrieval and already caused a significant decrease in freezing behavior by 
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itself during the first retention test (one-way ANOVA: F(4,37) = 9.187; p = 0.001, Fig. 6B). 
In the scrambled siRNA injected animals 8-pCPT-2’O-Me-cAMP injection again improved 
memory retrieval. Interestingly, when the Epac2 siRNA injected animals were re-exposed 
to the conditioning box 14 days after the first retention test, they showed high freezing 
levels that were comparable to untreated or control siRNA injected mice (one-way 
ANOVA: F(4,35) = 0.862; p = 0.496, Fig. 6C). Injection of Epac2 siRNA on three 
consecutive days prior to this delayed retention test also did not affect freezing in any of the 
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Fig. 6. Intrahippocampal injection of Epac2 siRNA impairs memory retrieval in contextual fear conditioning. Mice 
were injected with Epac2 or control siRNA 3 hr, 24 hr and 48 hr after training. Untreated mice served as additional 
controls. A. Experimental protocol B. Freezing behaviour was measured in the memory test 24 h after the last 
siRNA injection. C. Freezing behavior assessed during the second retention test 14 days after the first retention 
test. Where indicated this retention test was preceded by Epac2 siRNA injections on three consecutive days. Error 






In contrast to memory formation, the knowledge about the molecular mechanisms of 
memory retrieval is surprisingly limited due to the lack of tools to study this phase of the 
memory process. Most studies on memory using brain lesion and/or gene manipulation 
techniques cannot distinguish between effects on the molecular mechanisms of acquisition 
or consolidation of memories and those responsible for their retrieval from storage. Using 
the specific Epac activator 8-pCPT-2’O-Me-cAMP, we observed a surprisingly specific 
role of Epac signaling in associative fear memory retrieval whereas acquisition and 
consolidation were not affected. 
Ouyang and colleagues also recently reported a role for Epac signaling in memory retrieval 
(Ouyang et al., 2008). However, their design did not allow the investigation of Epac 
signaling in the different phases of the memory process. In their study, the memory 
retrieval impairment observed in dopamine-beta-hydroxylase deficient mice could be 
rescued by i.h. injection of a selective PKA activator together with a selective Epac 
activator whereas injection of one of the activators alone did not overcome the retrieval 
deficit. From these data they concluded that cAMP signaling via both Epac and PKA is 
required for retrieval (Ouyang et al., 2008). We report here that Epac activation alone can 
significantly improve memory retrieval in contextual fear conditioning. This retrieval-
enhancing effect was even stronger in a passive avoidance paradigm. 
 
Since 8-pCPT-2’O-Me-cAMP activates both Epac1 and Epac2 (Enserink et al., 2002), it 
was not possible to distinguish between the contribution of both Epac variants to the 
facilitation of memory retrieval. However, the finding in our and other studies that Epac2 is 
abundantly expressed in mouse brain whereas Epac1 is hardly detectable (Kawasaki et al., 
1998) together with our finding that downregulation of Epac2 expression in the 
hippocampus impairs memory retrieval, strongly suggests a role for Epac2 in memory 
retrieval. Interestingly, Epac2 silencing only led to impaired memory retrieval 3 days after 
conditioning whereas Epac2 silencing during the retention test 17 days after conditioning 
had no effect on memory retrieval indicating a time-limited function of Epac2 signaling 
after conditioning. These data are consistent with earlier data showing that signaling by 
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norepinephrine through the beta1-adrenergic receptor is also only required for an 
intermediate term of memory retrieval (Murchison et al., 2004). Since beta1-adrenergic 
receptors couple to cAMP via Gs, it is likely that this result is at least in part mediated by 
Epac2. In line with these findings activation of beta adrenergic receptors and 8-pCPT-2’O-
Me-cAMP were shown to recruit similar mechanisms to facilitate long-lasting hippocampal 
LTP (Gelinas et al., 2008). Also in several other cell systems such as the heart and vascular 
smooth muscle cells, a strong connection between beta-adrenergic signaling and Epac has 
already been established (Jensen, 2007; Métrich et al., 2008). 
From our finding that freezing was low in the Epac2 siRNA injected animals 3 days after 
conditioning but comparable to untreated and control siRNA injected animals 17 days after 
conditioning it can be concluded that Epac2 silencing in the hippocampus transiently 
affects memory retrieval instead of having a long-lasting effect on consolidation. Overall 
our data strengthen the hypothesis that retrieval may become independent of the 
hippocampus over time (McClelland et al., 1995; Squire et al., 2001; Wiltgen et al., 2004; 
Morris, 2006). However we cannot completely exclude the possibility that hippocampal 
signaling mechanisms other than Epac2 are involved in the delayed memory retrieval.  
 
The subcellular mechanism by which Epac2 modulates the retrieval of fear memory still 
remains to be elucidated. Although little information is available on downstream molecules 
of Epac signaling in the hippocampus, Epacs are known to function as cAMP-mediated 
guanine nucleotide-exchange factors (GEFs) activating the small GTP-ase proteins Rap1 
and Rap2 (Bos, 2006). Indeed, Ouyang and colleagues reported on unpublished data that 
the expression of a dominant-negative Rap construct in the dorsal hippocampus impairs 
memory retrieval in a manner identical to antagonists of beta1-adrenergic receptors, cAMP 
and PKA (Ouyang et al., 2008). Epac-Rap signaling has been reported to activate p42/p44 
mitogen-activated protein kinases (p42/p44 MAPK; ERK1/2) in cultured rat hippocampal 
neurons (Lin et al., 2003). Moreover, application of 8-pCPT-2’O-Me-cAMP leads to a 
transient increase in p42/44 MAPK immunoreactivity in hippocampal slices of the CA1 
area (Gelinas et al., 2008). Overall, MAPKs may have an important contribution in the 
memory enhancing effect of the Epac activator. Indeed, MAPK activation was observed to 
be increased in the hippocampus during memory retrieval (Szapiro et al., 2000), whereas 
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MAPK inhibition by intrahippocampal injection of the MAPK kinase inhibitor PD098059 
was shown to impair retrieval of an one-trial step-down avoidance task (Izquierdo et al., 
2000). 
Impaired retrieval is generally a sensitive measure of memory impairment in age-associated 
memory impairment (AAMI) and the early stages of Alzheimer’s disease. From our data it 
can be speculated that enhancing Epac2 signaling might at least in part overcome the 
memory retrieval deficits reported. In this respect it is interesting to note that the Epac2 
expression is reduced in brains showing Alzheimer’s pathology when compared to non-
diseased control brains. These changes were restricted to those regions of the brain 
associated with Alzheimer’s disease such as the frontal cortex and the hippocampus but not 
in the cerebellum, a region resistant to this pathology (McPhee et al., 2005). On the 
contrary, post-traumatic stress disorder (PTSD) is characterized by traumatic memories that 
can manifest as daytime recollections, traumatic nightmares, or flashbacks in which 
components of the event are relived. These symptoms reflect excessive retrieval of 
traumatic memories that often retain their vividness and power to evoke distress for decades 
or even a lifetime. It can be hypothesized that such conditions may benefit from reduced 
Epac2 signaling. 
 
Considering both the lack and the need of drugs proven to be effective in modulating 
memory retrieval, the specific effect of hippocampal Epac signaling on retrieval we 
observed is of particular interest and warrants further research into the role of Epac 
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